Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
39
Number of overlapping holdings
33.1%
% of XBI's 119 holdings also in SBIO
45.9%
% of SBIO's 90 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 1.1% | 4.5% | 1.1% |
 |
AVIDITY BIOSCIENCES INC | 1.1% | 3.2% | 1.1% |
|
CRINETICS PHARMACEUTICALS INC | 0.8% | 2.7% | 0.8% |
|
ACADIA PHARMACEUTICALS INC | 0.8% | 2.4% | 0.8% |
|
RHYTHM PHARMACEUTICALS, INC. | 0.7% | 3.0% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to SBIO
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.5% |
|
NATERA INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
BIOGEN IDEC INC | 2.5% |
|
AMGEN INC | 2.4% |
|
GILEAD SCIENCES INC | 2.4% |
|
ABBVIE INC | 2.4% |
XBI Underweight Relative to SBIO
|
AXSOME THERAPEUTICS, INC. | -4.5% |
|
ALKERMES PLC | -3.4% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.3% |
|
PTC THERAPEUTICS INC | -2.9% |
 |
MERUS N.V. | -2.7% |
|
RHYTHM PHARMACEUTICALS, INC. | -2.2% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.2% |
|
AKERO THERAPEUTICS, INC. | -2.2% |
|
AVIDITY BIOSCIENCES INC | -2.2% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.2% |